Fecal calprotectin is of great significance in the treatment of ulcerative colitis. Ulcerative colitis is a chronic inflammatory bowel disease characterized by chronic inflammation and ulceration of the colonic mucosa.

kjp-2019-00059i1

Fecal calprotectin is an inflammatory marker primarily released by neutrophils. Fecal calprotectin levels are often elevated in patients with ulcerative colitis, reflecting the extent of intestinal inflammatory activity.

The following is the importance of fecal calprotectin in the treatment of ulcerative colitis:

1) Diagnosis and Differentiation: When diagnosing ulcerative colitis, measuring fecal calprotectin levels can help doctors determine whether intestinal inflammation is present and differentiate it from other conditions, such as celiac disease caused by diarrhea or infectious enteritis.

2) Disease activity monitoring: Fecal calprotectin levels can be used as an indicator of inflammatory activity in ulcerative colitis. During treatment, doctors can assess the control of inflammation by regularly measuring fecal calprotectin levels and adjust treatment based on the results.

3)Predicting risk of recurrence: High levels of fecal calprotectin may indicate a higher risk of recurrence of ulcerative colitis. Therefore, by monitoring fecal calprotectin levels, doctors can take timely steps to prevent and manage the recurrence of ulcerative colitis.

4)Judgment of Treatment Response: The goals of treatment for ulcerative colitis are to reduce inflammatory activity and maintain remission. By regularly measuring fecal calprotectin levels, doctors can assess response to treatment and adjust drug doses or switch treatment strategies as needed.

In summary, fecal calprotectin is of great significance in the treatment of ulcerative colitis and can help doctors monitor inflammatory activity, predict the risk of recurrence, and guide treatment decisions to improve patients’ quality of life and disease management effects.

Our Fecal Calprotectin rapid test  with  good accuracy for our clients


Post time: Sep-20-2023